 COVID vaccine maker Moderna is receiving about $176 million from the federal government to develop an mRNA-based influenza vaccine that could be deployed against bird flu. The federal government also has other vaccines which are not mRNA-based coming online later this month. Those could go to people at increased risk like dairy farm workers. Dr. Nirav Shah with the CDC says the agency has not decided whether that's necessary.